Company / Operating Cash Flow per Share
Prime Medicine, Inc. Operating Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.04
FY2024
5-year range
-$3.89 / -$1.04
FY2020-FY2024
Trend
+43.0%
vs FY2023
Sector context
#112 of 208
Health Care
What the data says
At $-1.04, Prime Medicine, Inc.'s operating cash flow per share ranks #112 of 208 in the Health Care sector. Improved from $-3.89 to $-1.04 over the past 2 years.
Based on SEC 10-K filings.
-1.04 in FY2024.
Improved from $-3.89 to $-1.04 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#112 of 208 in Health CareTop 54% of 208This company -$1.04 Sector average -$21.21
▼
+95.1% above sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 43.0% year-over-year.
- Ranks #112 out of 208 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.04 | +43.0% |
| FY2023 | -$1.82 | +53.3% |
| FY2022 | -$3.89 | -48.1% |
| FY2021 | -$2.63 | -25.1% |
| FY2020 | -$2.10 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026